radium223diklorid

Radium-223 dichloride, also known as radium Ra 223 dichloride, is a radioactive compound of radium with the chemical formula RaCl2. It is a white crystalline solid that is highly soluble in water. Radium-223 is a decay product of radium-227, which is itself a decay product of actinium-227. It has a half-life of approximately 11.4 days and emits alpha particles.

Radium-223 dichloride is primarily used in the medical field for the treatment of bone metastases from prostate cancer. It is administered intravenously and selectively targets bone tissue, where it emits alpha particles that can damage cancer cells. The compound is produced by dissolving radium-223 in hydrochloric acid.

Due to its radioactivity, radium-223 dichloride must be handled with extreme care. It is classified as a Category 2 substance in the United States, meaning it requires special handling and disposal procedures. The International Atomic Energy Agency (IAEA) and other regulatory bodies have established guidelines for the safe use and disposal of radium-223 dichloride to minimize radiation exposure and environmental impact.